June 12, 2024

Gene Delivery Technologies Market Size To Rake USD 17.07 Bn By 2032

The global gene delivery technologies market size was valued at USD 4.01 billion in 2022 and is projected to reach USD 17.07 billion by 2032, growing at a CAGR of 15.59% from 2023 to 2032, According to Precedence Research.

Gene Delivery Technologies Market Size 2023 To 2032

The global gene delivery technologies market boons an in-depth synopsis of the competitive landscape of the market globally, thus helping establishments understand the primary threats and prospects that players/vendors in the market are dealt with. It also incorporates thorough business profiles of some of the prime vendors in the market.

Download The Sample Copy For Better Understanding@ https://www.precedenceresearch.com/sample/3021

Gene Delivery Technologies Market Report Scope

Report Coverage Details
Market Size in 2023 USD 4.63 Billion
Market Size by 2032 USD 17.07 Billion
Growth Rate from 2023 to 2032 CAGR of 15.59%
Largest Market North America
Base Year 2022
Forecast Period 2023 to 2032
Segments Covered By Delivery System, By Application, and By Method
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Also read: Portable Dishwasher Market Size To Rake USD 8.62 Bn By 2032

Benefits of this market

  • This study analyses the market size and share for gene delivery technologies along with the present trends in the industry and forecasts for the future, showing investment opportunities for the future.
  • In order to compare the financial capabilities of the gene delivery technologies market in the present, a quantitative analysis is done of the market from 2023 to 2032.
  • It is clear from this brilliant presentation of Porter’s Five Forces that buyers and suppliers have a lot of potential to gain from one another.
  • It is important to understand the most profitable trends in the gene delivery technologies market in order to gain an advantage in the market.
  • A comprehensive analysis of the driving factors, limitations, and opportunities is provided in the report, along with an in-depth analysis of the effect they have on the market.
  • The report also includes the market share for gene delivery technologies for several significant vendors as well as the latest developments in the market.

Leading players of the global gene delivery technologies market are analysed taking into account their market share, recent developments, new product launches, partnerships, mergers or acquisitions, and markets served. Precedence Research provide an exhaustive analysis of their product portfolios to explore the products and applications they concentrate on when operating in the global gene delivery technologies market. Furthermore, the report offers two separate market forecasts – one for the production side and another for the consumption side of the global gene delivery technologies market. It also provides useful recommendations for new as well as established players of the global gene delivery technologies market.

The major players in the market

  • Pfizer, Inc.
  • Becton, Dickinson and Company
  • Novartis AG
  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific, Inc.
  • QIAGEN
  • Horizon Discovery Group Co.
  • OriGene Technologies, Inc.
  • SignaGen Laboratories
  • Bio-Rad Laboratories, Inc.

Gene Delivery Technologies Market Segmentations:

By Delivery System

  • Viral Gene Delivery Systems
    • Adenovirus Systems
    • Lentiviral Systems
    • Retroviral Systems
    • Others
  • Non-Viral Gene Delivery System
  • Combined Hybrid Delivery Systems

By Application

  • Gene therapy
  • Cell therapy
  • Vaccines
  • Research

By Method

  • Ex Vivo
  • In Vivo
  • In Vitro

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Gene Delivery Technologies Market 

5.1. COVID-19 Landscape: Gene Delivery Technologies Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Gene Delivery Technologies Market, By Delivery System

8.1. Gene Delivery Technologies Market, by Delivery System, 2023-2032

8.1.1 Viral Gene Delivery Systems

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Non-Viral Gene Delivery System

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Combined Hybrid Delivery Systems

8.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Gene Delivery Technologies Market, By Application

9.1. Gene Delivery Technologies Market, by Application, 2023-2032

9.1.1. Gene therapy

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Cell therapy

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Vaccines

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. Research

9.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Gene Delivery Technologies Market, By Method

10.1. Gene Delivery Technologies Market, by March, 2023-2032

10.1.1. Ex Vivo

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. In Vivo

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. In Vitro

10.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Gene Delivery Technologies Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Delivery System (2020-2032)

11.1.2. Market Revenue and Forecast, by Application (2020-2032)

11.1.3. Market Revenue and Forecast, by Method(2020-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Delivery System (2020-2032)

11.1.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.1.4.3. Market Revenue and Forecast, by Method(2020-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Delivery System (2020-2032)

11.1.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.1.5.3. Market Revenue and Forecast, by Method(2020-2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Delivery System (2020-2032)

11.2.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.3. Market Revenue and Forecast, by Method(2020-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Delivery System (2020-2032)

11.2.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.4.3. Market Revenue and Forecast, by Method(2020-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Delivery System (2020-2032)

11.2.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.5.3. Market Revenue and Forecast, by Method(2020-2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Delivery System (2020-2032)

11.2.6.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.6.3. Market Revenue and Forecast, by Method(2020-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Delivery System (2020-2032)

11.2.7.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.7.3. Market Revenue and Forecast, by Method(2020-2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Delivery System (2020-2032)

11.3.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.3. Market Revenue and Forecast, by Method(2020-2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Delivery System (2020-2032)

11.3.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.4.3. Market Revenue and Forecast, by Method(2020-2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Delivery System (2020-2032)

11.3.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.5.3. Market Revenue and Forecast, by Method(2020-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Delivery System (2020-2032)

11.3.6.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.6.3. Market Revenue and Forecast, by Method(2020-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Delivery System (2020-2032)

11.3.7.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.7.3. Market Revenue and Forecast, by Method(2020-2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Delivery System (2020-2032)

11.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.3. Market Revenue and Forecast, by Method(2020-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Delivery System (2020-2032)

11.4.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.4.3. Market Revenue and Forecast, by Method(2020-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Delivery System (2020-2032)

11.4.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.5.3. Market Revenue and Forecast, by Method(2020-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Delivery System (2020-2032)

11.4.6.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.6.3. Market Revenue and Forecast, by Method(2020-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Delivery System (2020-2032)

11.4.7.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.7.3. Market Revenue and Forecast, by Method(2020-2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Delivery System (2020-2032)

11.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.5.3. Market Revenue and Forecast, by Method(2020-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Delivery System (2020-2032)

11.5.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.5.4.3. Market Revenue and Forecast, by Method(2020-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Delivery System (2020-2032)

11.5.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.5.5.3. Market Revenue and Forecast, by Method(2020-2032)

Chapter 12. Company Profiles

12.1. Pfizer, Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Becton, Dickinson and Company

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Novartis AG

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. F. Hoffmann-La Roche Ltd

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Thermo Fisher Scientific, Inc.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. QIAGEN

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Horizon Discovery Group Co.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. OriGene Technologies, Inc.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. SignaGen Laboratories

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Bio-Rad Laboratories, Inc.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Key inquiries addressed in the report:

  • Investigate the COVID 19 outbreak’s effects.
  • Our researchers give precise responses, pinpoint significant chances and fresh investments, and suggest excellent market strategy avenues.

Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/

About Us

Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.

From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.

Contact Us:                  

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com

Leave a Reply

Your email address will not be published. Required fields are marked *